Suchergebnisse - "Zeng, Furong"

PubPharm (85)

21

Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients : A meta‐analysis

enthalten in: MedComm | 2023

von Deng, G. | Zhou, Q. | Meng, Y. | +4

22

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression

enthalten in: Experimental & molecular medicine | 2023

von Zeng, F. | Li, Y. | Meng, Y. | +5

23

Clinical characteristics and outcomes of patients with COVID-19 and psoriasis

enthalten in: Journal of medical virology | 2022

von Meng, Y. | Zeng, F. | Sun, H. | +3

24

The anti-ferroptotic role of FSP1 : current molecular mechanism and therapeutic approach

enthalten in: Molecular biomedicine | 2022

von Zeng, F. | Chen, X. | Deng, G.

25

The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approach

enthalten in: Molecular biomedicine | 2022

von Zeng, F. | Chen, X. | Deng, G.

26

Melanoma survivors are at increased risk for second primary keratinocyte carcinoma

enthalten in: International journal of dermatology | 2022

von Sun, H. | Li, Y. | Zeng, F. | +3

27

The risk of developing second primary malignancies among colorectal cancer patients

enthalten in: Aging | 2022

von Du, S. | Li, Y. | Sun, H. | +5

28

The Risk of Rheumatoid Arthritis among Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

enthalten in: ResearchSquare.com | 2022

von Chen, Y. | Chen, L. | Xing, C. | +5

29

The Risk of Rheumatoid Arthritis among Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

enthalten in: ResearchSquare.com | 2022

von Chen, Y. | Chen, L. | Xing, C. | +5

30

The Risk of Developing Second Primary Malignancies Among Colorectal Cancer Patients

enthalten in: ResearchSquare.com | 2022

von Du, S. | Li, Y. | Sun, H. | +4